Particle Data Platform

Finding Middle Ground On FDA

47:4649:29 · 102s

Steve lays out a pragmatic stance: supplements need a consumer trust layer, while peptides face overregulation; the future is elevating quality N=1 data.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.